Trial intelligence / Profile preview

Comparative Effectiveness of ESWT Combined With Injection Treatments in Athletes With Chronic Patellar Tendinopathy

NCT07819968Active, not recruiting

Sponsor
Chang Gung Memorial Hospital
Start
Sep 2026
Primary completion
Jul 2027
Countries
1
01

Overview

Randomised, single-blind trial of hyaluronic acid and platelet-rich plasma in patellar tendinopathy (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Visual Analogue Scale at 3 months. Started Sep 2026; status: active, not recruiting.

02

Drugs

hyaluronic acidplatelet-rich plasma
03

Conditions

patellar tendinopathy

Beyond the preview

Go deeper on NCT07819968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07819968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call